Skip to content

TG THERAPEUTICS, INC.: 10-Q/A filed 2011-09-14

What TG THERAPEUTICS, INC. reported in its quarterly report amendment filed 2011-09-14 (fiscal Q2 2011): 23 published measures, 95 facts as tagged in accession 0001144204-11-052935.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2011-09-14
Fiscal period
fiscal Q2 2011
Accession
0001144204-11-052935 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TG THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-3018,361,010USD
At 2010-12-3118,635,641USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-06-3020,510,557USD
At 2010-12-3123,999,942USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-06-30-2,149,547USD
At 2010-12-31-5,364,301USD
At 2009-12-31-6,784,951USD
At 2008-12-31-4,375,926USD
At 2007-12-31-891,086USD
At 2006-12-311,504,628USD
At 2005-12-319,540,496USD
At 2004-12-314,150,405USD
At 2003-12-316,832,932USD
At 2002-12-31637,923USD
At 2001-12-31-56,796USD
At 2000-12-310USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-06-30492,508USD
At 2010-12-31478,668USD
At 2010-06-301,572,031USD
At 2009-12-3117,996USD
At 2001-08-050USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-2,982,539USD91
2011-01-01 to 2011-06-30849,844USD181
2001-08-06 to 2011-06-30-59,280,301USD3616
2010-01-01 to 2010-12-31623,645USD365
2010-04-01 to 2010-06-301,850,336USD91
2010-01-01 to 2010-06-30217,167USD181
2009-01-01 to 2009-12-31-2,793,285USD365
2008-01-01 to 2008-12-31-4,268,858USD366
2007-01-01 to 2007-12-31-12,032,252USD365
2006-01-01 to 2006-12-31-9,695,123USD365
2005-01-01 to 2005-12-31-19,140,997USD365
2004-01-01 to 2004-12-31-5,896,031USD366
2003-01-01 to 2003-12-31-5,960,907USD365
2002-01-01 to 2002-12-31-1,037,320USD365
2001-01-01 to 2001-12-31-56,796USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-06-30113,840USD181
2001-08-06 to 2011-06-30-41,525,637USD3616
2010-01-01 to 2010-06-30-1,015,638USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-06-300USD181
2001-08-06 to 2011-06-30242,452USD3616
2010-01-01 to 2010-06-302,844USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-100,000USD181
2001-08-06 to 2011-06-3041,131,324USD3616
2010-01-01 to 2010-06-302,053,152USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-06-300USD181
2001-08-06 to 2011-06-30886,821USD3616
2010-01-01 to 2010-06-30516,521USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-301,816USD
At 2010-12-312,984USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2011-01-01 to 2011-06-3013,613USD181
2001-08-06 to 2011-06-304,413,403USD3616
2010-01-01 to 2010-06-30206,141USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-322,906USD91
2011-01-01 to 2011-06-30-888,991USD181
2001-08-06 to 2011-06-30-63,781,307USD3616
2010-04-01 to 2010-06-30-525,091USD91
2010-01-01 to 2010-06-30-1,054,536USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-30609,334USD
At 2010-12-31869,177USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-04-01 to 2011-06-30428,210USD91
2011-01-01 to 2011-06-30717,808USD181
2001-08-06 to 2011-06-302,630,256USD3616
2010-04-01 to 2010-06-30351,215USD91
2010-01-01 to 2010-06-30587,992USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-303,782,728USD
At 2010-12-313,293,498USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-04-01 to 2011-06-3090,218USD91
2011-01-01 to 2011-06-30445,395USD181
2001-08-06 to 2011-06-3029,273,399USD3616
2010-04-01 to 2010-06-3050,999USD91
2010-01-01 to 2010-06-3068,766USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-302,595,866shares
At 2010-12-312,419,305shares

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-06-307,750USD
At 2010-12-3121,370USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-2,982,539USD91
2011-01-01 to 2011-06-30849,844USD181
2001-08-06 to 2011-06-30-60,459,946USD3616
2010-04-01 to 2010-06-301,850,336USD91
2010-01-01 to 2010-06-30217,167USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30232,688USD91
2011-01-01 to 2011-06-30443,596USD181
2001-08-06 to 2011-06-3020,157,993USD3616
2010-04-01 to 2010-06-30474,092USD91
2010-01-01 to 2010-06-30985,770USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-06-301,168USD181
2001-08-06 to 2011-06-30232,031USD3616
2010-01-01 to 2010-06-302,383USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2011-01-01 to 2011-06-300USD181
2001-08-06 to 2011-06-30145,162USD3616
2010-01-01 to 2010-06-300USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-06-300USD181
2001-08-06 to 2011-06-3028,059,748USD3616
2010-01-01 to 2010-06-302,163,486USD181

Inspect the source

Entity
TG THERAPEUTICS, INC. / CIK 0001001316
Captured
2026-09-20T05:11:16.212Z
SEC response SHA-256
153d276440c1903144d2ca193676af4b7014428a3e4b5524efe33528427880b3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001001316.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))